ResMed, Inc. (RMD)

260.70 +1.19 (+0.46%) USD  |  NYSE  |  Jan 15, 16:00
260.74 +0.04 (+0.02%) Pre-Market: 20:00
More

ResMed Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for RMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Abbott Laboratories Upgrade
Stryker Corp. Upgrade
West Pharmaceutical Services, Inc. Upgrade
Insulet Corp. Upgrade